Through subsidiary NextChem Holding, Maire Tecnimont is taking an 83.5% stake in Italian technology licensor and process engineering design company Conser, expanding its portfolio into high-value specialty chemicals and biodegradable plastics.
Indian drugmaker Sun Pharmaceutical Industries is to buy US biotech Concert Pharmaceuticals, gaining access to the latter’s lead product candidate deuruxolitinib for treating an autoimmune dermatological disease.
As well as serving as a financial partner to fledgling companies, the VC fund supports future efforts for business development and M&A opportunities within its own operations, Sanofi said. The fresh capital injection will also fuel the expansion and investment capacity of its own investment team on a global scale.
Ineos Enterprises has signed an agreement to buy MBCC Group’s admixture business from Sika. The deal is required by European antitrust regulators to approve Sika’s purchase of the MBCC Group, formerly BASF Construction Chemicals. The transaction is scheduled to complete in the first half of this year, subject to regulatory approvals.
Canada’s Fluid Energy Group has sold its global modified and synthetic acid business, including the Triton industrial business, to Dorf Ketal FZE, a wholly owned subsidiary of Dorf Ketal Chemicals India, for an undisclosed sum.
Specialty chemicals and food ingredients distributor Azelis has acquired 100% of Benelux smoke ingredients distributor Smoky Light.
Nouryon announced on Jan. 4 that it had closed its purchase of ADOB, a Poland-based supplier of chelated micronutrients, foliars and other specialty agricultural solutions.
German distribution giant Brenntag is retreating from plans to acquire US rival Univar. The company said in an ad hoc statement that it is “no longer pursuing these discussions.”
UK chemicals company Synthomer is selling its laminates, films and coated fabrics businesses to Germany’s Surteco Group for $255 million. The sale is part of Synthomer’s realignment of its portfolio to focus on specialty chemicals.
Japanese pharma Takeda is acquiring Nimbus Lakshmi, a wholly-owned subsidiary of US clinical-stage drug discovery company Nimbus Therapeutics, and its tyrosine kinase 2 (TYK2) inhibitor NDI-034858, which is undergoing trials for treating multiple autoimmune diseases, including psoriasis.
Amgen has agreed to buy Horizon Therapeutics for $28.3 billion including debt, boosting its portfolio of drugs for rare autoimmune and inflammatory diseases and beating rivals Sanofi and Johnson & Johnson, as well as a fourth unnamed company.
Danish companies Novozymes and Chr. Hansen have agreed to merge, in a move they termed a perfect match that will create a global leader in biosolutions.
Dussur, the Saudi Arabian Industrial Investments Company, has agreed to buy a stake in Italian specialty additives manufacturer Italmatch Chemicals from private equity group Bain Capital. The Riyadh-based group will also invest €100 million in Italmatch as a capital increase.
Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The company is based in the US state of Massachusetts.
US contract research organization Reaction Biology has acquired German contract laboratory Bioassay Labor für biologische Analytik and its wholly owned subsidiary Peptide Specialty Laboratories (PSL).
Consolidation in the distribution sector continues apace. Specialty chemicals and food ingredients distributor Azelis has entered into an agreement to take over Chemiplas, a leading distributor of specialty chemicals, plastic raw materials and ingredients in Australia, New Zealand and the Pacific Islands.
US agricultural chemicals and seeds group Corteva has agreed to buy Stoller Group, a compatriot producer of biostimulants and plant nutrition products, for $1.2 billion in cash. The transaction is expected to close in the first half of 2023.
UK specialty chemicals company Elementis has agreed to sell its chromium business to the Yildirim Group for $170 million. The deal values the business at 7.3 times the EBITDA posted in fiscal 2022 (30 June.)
AstraZeneca has agreed to acquire Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacture of next-generation T-cell receptor therapies (TCR-Ts) – a promising and novel cell therapy approach to target cancer.
Shell has sealed a definitive agreement to buy Europe’s largest biogas producer, Denmark’s Nature Energy, for €1.9 billion. The move is being seen as another sign of a former oil major’s effort to diversify its portfolio and reduce the dependence on fossil fuels that put it on the energy map.
Brenntag and Univar Solutions have both confirmed reports from late last week that they are in talks about the German-multinational chemical distributor acquiring its US rival. Both companies stress that the negotiations are at a preliminary stage.
Following all approvals, International Chemical Investors (ICIG) has completed its acquisition of the compounds business of the French Benvic group. The closing follows a binding agreement signed in August.
US CDMO Cambrex has agreed to buy Snapdragon Chemistry, a compatriot company specializing in developing continuous flow and batch processes for APIs. Snapdragon is based in Waltham, Massachusetts, where it employs 74 people.
US titanium dioxide pigments and performance additives producer Venator Materials has agreed to sell its iron oxide business to Hong Kong’s Cathay Industries for an enterprise value of $140 million. The transaction is expected to close by the end of quarter one 2023.
International Chemical Investors Group (ICIG) has entered exclusive negotiations with Nippon Soda and made what it said is a “firm and binding offer” to acquire the Japanese group’s offshoot Métaux Spéciaux (MSSA), a sodium metal specialist.
British drugmaker Indivior has agreed to buy Opiant, a US biotech specializing in treatments for addiction and drug overdose. Indivior will pay about $145 million upfront, plus another $68 million if Opiant hits revenue milestones.
Angus Chemical Company, a US-based global manufacturer and marketer of specialty ingredients for life sciences and industrial markets, has acquired Expression Systems, a compatriot manufacturer of cell culture media, baculovirus molecular reagents and cell lines used in advanced biological-based therapeutics.
UK specialist healthcare investor GHO Capital Partners and US investment firm The Vistria Group have entered into an agreement to buy a controlling interest in US CDMO Alcami from current private equity owners Madison Dearborn Partners (MDP) and Ampersand Capital Partners. Financial terms of the deal were not disclosed.
Turkish industrial conglomerate Yildirim will now launch a mandatory takeover bid for fertilizer producer Rosier – and a squeeze-out offer for the remaining shares – once the acquisition from Borealis has closed.
US nylon giant Ascend Performance Materials has acquired an undisclosed majority stake in compatriot Circular Polymers, a recycler of post-consumer high-performance polymers including PA 6 and 6.6, polypropylene and PET.
DuPont has terminated the agreement announced in November last year to acquire the outstanding shares of electronics materials specialist Rogers Corporation for $5.2 billion.
Indian specialty chemical company Dorf Ketal has agreed to acquire Clariant’s North American land oil business for an undisclosed sum.
Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens Symeres’ foothold in the US, where it already generates about 50% of its revenues.
Italy’s SABO, a producer of polymer additives, cosmetics ingredients and specialized products for a variety of zootechnical and industrial applications, is acquiring the TAA derivatives business of Germany’s Evonik, including two production sites at Marl, Germany, and Liaoyang, China.
Canadian pharma Sunshine Biopharma has taken over compatriot company Nora Pharma for C$30 million.
